151PSafety and tolerability of pembrolizumab or placebo...

Annals of Oncology 2019 / 04 Vol. 30; Iss. Supplement

151PSafety and tolerability of pembrolizumab or placebo plus pemetrexed and platinum as first-line therapy in Japanese patients (PTS) with metastatic non-squamous non-small cell lung cancer (NSCLC) enrolled in the phase III KEYNOTE-189 study

Horinouchi, H, Nogami, N, Saka, H, Nishio, M, Tokito, T, Takahashi, T, Kasahara, K, Hattori, Y, Ichihara, E, Adachi, N, Sawada, T, Shimamoto, T, Noguchi, K, Pietanza, M C, Kurata, T
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
30
Language:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdz063.049
Date:
April, 2019
File:
PDF, 92 KB
english, 2019
Conversion to is in progress
Conversion to is failed